Publication Ethics and Malpractice Statement

Current Pharmaceutical Letters And Reviews (CPLR) is dedicated to upholding the highest standards of integrity in the content it publishes.

Responsible Research Publication:  Authors' Responsibilities

Authors are expected to conduct their research ethically and responsibly, complying with all relevant legislation. They must avoid scientific misconduct, including fabrication, falsification, or inappropriate data manipulation.

Authors should transparently present their results and methods, ensuring clarity and originality. All authors must have contributed significantly to the research and should be acknowledged accordingly.

Authors must disclose any conflicts of interest with editors, members of the editorial board, or the International scientific committee.

Publication Decision

Current Pharmaceutical Letters And Reviews (CPLR) employs a double-blind review process. The editor is responsible for selecting articles that align with the journal's goals and are of importance to researchers and practitioners. Editorial decisions are unbiased and independent of commercial considerations.

Editors must withdraw from editorial decisions if they have conflicts of interest. The responsibility for the final decision rests with an editor without conflicts of interest.

Conflict of Interest

Any conflict of interest involving the chief editor, editorial board members, scientific committee members, or reviewers regarding an author or manuscript content will result in their withdrawal from the evaluation process.

Current Pharmaceutical Letters And Reviews (CPLR) avoids conflicts of interest among authors, reviewers, and editorial board members.

Peer Review

Each submitted article is evaluated by two anonymous expert peers selected by a member of the editorial board or the international scientific committee.

Reviewed articles are treated confidentially by editorial board members and reviewers.

Identifying and Preventing Misconduct

Current Pharmaceutical Letters And Reviews (CPLR) does not condone misconduct and takes measures to prevent it by informing authors and reviewers of ethical conduct expectations.

The editorial board, scientific committee, and reviewers are vigilant in identifying and addressing research misconduct.

Guidelines for Retraction or Corrections

Editors are responsible for addressing misconduct issues. They collaborate with co-editors, editorial board members, peer reviewers, and experts to resolve such issues.

Data Access and Retention

Authors are encouraged to share research data supporting their publications. They must provide a data statement indicating the source of their data.

Copyright, Content Originality, Plagiarism, and Reproduction

Authors retain intellectual property and copyright of their original content. By publishing in JCARR, authors grant the journal exclusive first publication rights.

Authors must ensure the originality of their material and avoid plagiarism or false declarations.

Access, Licensing, and Archiving

Current Pharmaceutical Letters And Reviews (CPLR) articles are published under a Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International license (CC BY-NC-ND 4.0) to ensure open access.

The journal's content is archived by Open Edition, ensuring continued free access.

Confidentiality Policy

Names of authors, reviewers, and collaborators, along with their affiliations, remain confidential and are not used for commercial purposes. Confidentiality is maintained during peer review.

Current Pharmaceutical Letters And Reviews (CPLR) may use this information for soliciting contributions or collaborations and flagging forthcoming issues, while maintaining anonymity in transmission.